Log In
Sunday 23rd October 2016

Meningitis breakthrough

23rd February 2007

British researchers have gained fresh insight into why meningitis is so resilient and hope their findings could lead to the development of new treatments.

The team at Imperial College, London discovered that, in the case of meningitis, two enzymes work together to stop the body's immune system from fighting the disease and actually repair the virus’s DNA even after white blood cells have tried to destroy them. This new understanding of how enzymes repair DNA could help scientists produce ways to immobilise them which could in turn lead to the development of new treatments for meningitis and septicaemia.

Professor Paul Freemont from Imperial College said, "This work provides an insight into the precise roles of two enzymes in mending DNA and gives us a greater understanding than ever before into why these infections are so hard for the body to fight."

Meningitis and septicaemia are deadly diseases that can kill within hours. Meningitis causes inflammation of the lining around the brain and spinal cord and septicaemia is the blood poisoning form of the disease. It is estimated that between 3,500 and 4,000 people are affected annually.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Meningitis breakthrough
Author: Martine Hamilton
Article Id: 2102
Date Added: 23rd Feb 2007



Recent Related Articles

Zika mosquito eggs found in UK

September heatwave to hit the UK

Students urged to get meningitis W vaccine

Poverty costing UK £78bn a year


Add to scrapbook
Show Comments
Add comment
Find all related articles


Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016